Kier Larry D, Petrick Jay S
Monsanto Company, 800 North Lindbergh Blvd., Mail Code O3F, St. Louis, MO 63167, USA.
Food Chem Toxicol. 2008 Aug;46(8):2591-605. doi: 10.1016/j.fct.2008.05.025. Epub 2008 Jun 3.
The current globally recognized comparative food and feed safety assessment paradigm for biotechnology-derived crops is a robust and comprehensive approach for evaluating the safety of both the inserted gene product and the resulting crop. Incorporating many basic concepts from food safety, toxicology, nutrition, molecular biology, and plant breeding, this approach has been used effectively by scientists and regulatory agencies for 10-15 years. Current and future challenges in agriculture include the need for improved yields, tolerance to biotic and abiotic stresses, and improved nutrition. The next generation of biotechnology-derived crops may utilize regulatory proteins, such as transcription factors that modulate gene expression and/or endogenous plant pathways. In this review, we discuss the applicability of the current safety assessment paradigm to biotechnology-derived crops developed using modifications involving regulatory proteins. The growing literature describing the molecular biology underlying plant domestication and conventional breeding demonstrates the naturally occurring genetic variation found in plants, including significant variation in the classes, expression, and activity of regulatory proteins. Specific examples of plant modifications involving insertion or altered expression of regulatory proteins are discussed as illustrative case studies supporting the conclusion that the current comparative safety assessment process is appropriate for these types of biotechnology-developed crops.
当前全球公认的针对生物技术衍生作物的食品和饲料安全性比较评估范式,是一种用于评估插入基因产物和所得作物安全性的强大而全面的方法。该方法融合了食品安全、毒理学、营养、分子生物学和植物育种等诸多基本概念,科学家和监管机构已有效运用该方法10至15年。农业当前和未来面临的挑战包括提高产量、增强对生物和非生物胁迫的耐受性以及改善营养状况。下一代生物技术衍生作物可能会利用调控蛋白,例如调节基因表达和/或植物内源途径的转录因子。在本综述中,我们讨论了当前安全性评估范式对使用涉及调控蛋白的修饰技术开发的生物技术衍生作物的适用性。越来越多描述植物驯化和传统育种背后分子生物学的文献表明,植物中存在自然发生的遗传变异,包括调控蛋白的种类、表达和活性方面的显著变异。文中讨论了涉及调控蛋白插入或表达改变的植物修饰的具体实例,作为说明性案例研究,以支持当前比较安全性评估过程适用于这类生物技术开发作物的结论。